PTGS1 and Alzheimer disease: Due to the upregulation of cyclooxygenase-1 in the microglia in AD, several epidemiologic studies have shown that NSAIDs reduce behavioral and pathological defects in transgenic mouse models of AD (McGeer and McGeer, 2007).